XML 20 R4.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS)          
Revenues $ 100,606 $ 81,959 $ 345,592 $ 317,750 $ 260,135
Transaction costs 20,155 24,793 97,040 94,665 81,368
Other operating expenses 26,614 19,852 81,976 82,295 68,883
Research and development expenses 16,653 10,574 52,301 34,772 29,383
Sales and marketing expenses 23,139 17,829 76,846 61,020 50,165
General and administrative expenses 10,517 7,826 37,629 31,016 24,389
Depreciation and amortization 4,677 4,166 17,095 10,341 7,874
Total operating expenses 101,755 85,040 362,887 314,109 262,062
Operating income (loss) (1,149) (3,081) (17,295) 3,641 (1,927)
Financial income (loss), net: 622 1,803 2,012 524 (2,173)
Income (loss) before taxes on income (1,771) (4,884) (15,283) 4,165 (4,100)
Income tax 1,731 2,573 8,320 4,709 3,089
Share in losses of associated company 6 22 143 81  
Net loss $ (3,508) $ (7,479) $ (23,746) $ (625) $ (7,189)
Per share data          
Net loss per share attributable to common stockholders - basic and diluted $ (0.31) $ (0.47) $ (1.50) $ (0.63) $ (1.05)
Weighted average common shares outstanding - basic and diluted 29,185,545 22,045,779 25,004,093 19,210,017 17,046,120